Updates are available Correction dated 2024-09-14

Article History

Received: 27 February 2024

Accepted: 24 June 2024

First Online: 4 July 2024

Change Date: 14 September 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00277-024-05995-3

Declarations

:

: The study was approved by Findata, permission THL/3276/14.02.00/2021 and Statistics Finland, permission TK/1449/07.03.00/2022 in accordance with the act on the secondary use of health and welfare data in Finland.

: KK, IT, AA and MIL are employees of Medaffcon Oy. TM was an employee of Takeda Finland and Medaffcon Oy. JL has received consultation fees from Amgen, Celgene, Bristol-Myers Squibb, Sanofi, Takeda, Janssen, and travel grants from Janssen, Celgene, Amgen, Novartis, TEVA, Takeda, Roche, Abbvie and Pfizer.AP reports honoraria from Behring and Abbvie and has participated in Scientific Advisory Board meetings organized by Abbvie, Janssen-Cilag, Novartis, Pfizer and Takeda. RS has received research funding from Amgen, BMS, Celgene, Janssen-Cilag and Takeda and honoraria from the same companies (Advisory Board and presentations).MP has received honoraria from Amgen, Celgene, Janssen-Cilag and Takeda (Advisory Board and presentations). TM was an employee of Takeda Finland and Medaffcon Oy. JL has received consultation fees from Amgen, Celgene, Bristol-Myers Squibb, Sanofi, Takeda, Janssen, and travel grants from Janssen, Celgene, Amgen, Novartis, TEVA, Takeda, Roche, Abbvie and Pfizer. AP reports honoraria from Behring and Abbvie and has participated in Scientific Advisory Board meetings organized by Abbvie, Janssen-Cilag, Novartis, Pfizer and Takeda. RS has received research funding from Amgen, BMS, Celgene, Janssen-Cilag and Takeda and honoraria from the same companies (Advisory Board and presentations). MP has received honoraria from Amgen, Celgene, Janssen-Cilag and Takeda (Advisory Board and presentations).